Endothelial nitric-oxide synthase activation generates an inducible nitric-oxide synthase-like output of nitric oxide in inflamed endothelium

Journal of Biological Chemistry

Volumn 288, Issue 6, 2013, Pages 4174-4193

  Lowry, Jessica L ^a   Brovkovych, Viktor ^a   Zhang, Yongkang ^a   Skidgel, Randal A ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASAL ACTIVITIES; CYTOKINE TREATMENT; EXTRACELLULAR; HIGH OUTPUT; HUMAN LUNG; IN-CONTROL; INDUCIBLE NITRIC OXIDE SYNTHASE (INOS); INFLAMMATORY CONDITIONS; INTERLEUKIN-1; INTRACELLULAR CA; MICROVASCULAR ENDOTHELIAL CELLS; NITRIC-OXIDE SYNTHASE; NO PRODUCTIONS; THERAPEUTIC TARGETS; VASCULATURE;

CALMODULIN; ENDOTHELIAL CELLS; ENZYME ACTIVITY; NITRIC OXIDE; PHOSPHORYLATION;

CALCIUM;

BRADYKININ; BRADYKININ B2 RECEPTOR; CALCIUM ION; CALMODULIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GAMMA INTERFERON; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PHOSPHOTRANSFERASE INHIBITOR; SERINE; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE 1; THREONINE;

ARTICLE; CALCIUM CELL LEVEL; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RECEPTOR BLOCKING; VASCULAR ENDOTHELIUM; VASCULITIS;

ARGININE; BRADYKININ; CALCIUM; CALCIUM SIGNALING; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; HEK293 CELLS; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; MAP KINASE KINASE 1; MAP KINASE KINASE 2; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASE 9; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; RECEPTOR, BRADYKININ B2; VASCULITIS;

EID: 84873652897     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.436022     Document Type: Article

References (91)

1. Alderton, W. K., Cooper, C. E., and Knowles, R. G. (2001) Nitric oxide synthases. Structure, function, and inhibition. Biochem. J. 357, 593-615
2. Aktan, F. (2004) iNOS-mediated nitric oxide production and its regulation. Life Sei. 75, 639-653
3. Kleinert, H., Pautz, A., Linker, IC, and Schwarz, P. M. (2004) Regulation of the expression of inducible nitric oxide synthase. Eur. J. Pharmacol. 500, 255-266
4. Villanueva, C, and Giulivi, C. (2010) Subcellular and cellular locations of nitric oxide synthase isoforms as determinants of health and disease. Free Radie. Biol. Med. 49, 307-316
5. Hill, B. G., Dranka, B. P., Bailey, S. M., Lancaster, J. R., Jr., and Darley-Usmar, V. M. (2010) What part of NO don't you understand? Some answers to the cardinal questions in nitric oxide biology. Biol. Chem. 285, 19699-19704
6. Albrecht, E. W., Stegeman, C. A., Heeringa, P., Henning, R. H., and van Goor, H. (2003) Protective role of endothelial nitric oxide synthase. J. Pathol. 199, 8-17
7. Cooke, J. P., and Dzau, V. J. (1997) Derangements of the nitric oxide synthase pathway, L-arginine, and cardiovascular diseases. Circulation 96, 379-382
8. Beekman, J. S., and Koppenol, W. H. (1996) Nitric oxide, superoxide, and peroxynitrite. The good, the bad, and the ugly. Am. J. Physiol. 271, C1424-C1437
9. Zamora, R., Vodovotz, Y., and Billiar, T. R. (2000) Inducible nitric oxide synthase and inflammatory diseases. Mol. Med. 6, 347-373
10. Chatterjee, A., Black, S. M., and Catravas, J. D. (2008) Endothelial nitric oxide (NO) and its pathophysiologic regulation. Vascul. Pharmacol. 49, 134-140
11. 745. J. Biol. Chem. 282, 32453-32461
12. Brovkovych, V., Zhang, Y., Brovkovych, S., Minshall, R. D., and Skidgel, R. A. (2011) A novel pathway for receptor-mediated post-translational activation of inducible nitric oxide synthase, J. Cell. Mol. Med. 15, 258-269
13. Kuhr, F. IC, Zhang, Y., Brovkovych, V., and Skidgel, R. A. (2010) β-Arrestin 2 is required for Bl receptor-dependent post-translational activation of inducible nitric oxide synthase. FASEB J. 24, 2475-2483
14. Cirino, G., Fiorucci, S., and Sessa, W. C. (2003) Endothelial nitric oxide synthase. The Cinderella of inflammation? Trends Pharmacol. Sei. 24, 91-95
15. Bhoola, K. D., Figueroa, C. D., and Worthy, K. (1992) Bioregulation of kinins. Kallikreins, kininogens, and kininases. Pharmacol. Rev. 44, 1-80
16. Leeb-Lundberg, L. M., Marceau, F., Müller-Esterl, W., Pettibone, D. J., and Zuraw, B. L. (2005) International union of pharmacology. XLV. Classification of the kinin receptor family. From molecular mechanisms to pathophysiological consequences. Pharmacol. Rev. 57, 27-77
17. Zhang, X., Tan, F., Brovkovych, V., Zhang, Y., and Skidgel, R. A. (2011) Cross-talk between carboxypeptidase M and the kinin Bl receptor mediates a new mode of G protein-coupled receptor signaling, J. Biol. Chem. 286, 18547-18561
18. Zhang, X., Tan, F., Zhang, Y., and Skidgel, R. A. (2008) Carboxypeptidase M and kinin Bl receptors interact to facilitate efficient Bl signaling from B2 agonists. Biol. Chem. 283, 7994-8004
19. Kuhr, F., Lowry, J., Zhang, Y., Brovkovych, V., and Skidgel, R. A. (2010) Differential regulation of inducible and endothelial nitric oxide synthase by kinin Bl and B2 receptors. Neuropeptides 44, 145-154
20. Venema, R. C. (2002) Post-translational mechanisms of endothelial nitric oxide synthase regulation by bradykinin. Int. Immunopharmacol. 2, 1755-1762
21. Sangsree, S., Brovkovych, V., Minshall, R. D., and Skidgel, R. A. (2003) Kininase I-type carboxypeptidases enhance nitric oxide production in endothelial cells by generating bradykinin Bl receptor agonists. Am. J. Physiol. Heart Circ. Physiol. 284, H1959-H1968
22. Fulton, D., Gratton, J. P., and Sessa, W. C. (2001) Post-translational control of endothelial nitric oxide synthase. Why isn't calcium/calmodulin enough? Pharmacol. Exp. Eher. 299, 818-824
23. Dudzinski, D. M., and Michel, T. (2007) Life history of eNOS. Partners and pathways. Cardiovasc. Res. 75, 247-260
24. Rafikov, R., Fonseca, F. V., Kumar, S., Pardo, D., Darragh, C, Elms, S., Fulton, D., and Black, S. M. (2011) eNOS activation and NO function, structural motifs responsible for the posttranslational control of endothelial nitric oxide synthase activity. Endocrinol. 210, 271-284
25. Harris, M. B., Ju, H, Venema, V. J., Liang, H, Zou, R., Michell, B. J., Chen, Z. P., Kemp, B. E., and Venema, R. C. (2001) Reciprocal phosphorylation and regulation of endothelial nitric-oxide synthase in response to brady-kinin stimulation. Biol. Chem. 276, 16587-16591
26. Fleming, I. (2010) Molecular mechanisms underlying the activation of eNOS. Pflugers Arch. 459, 793-806
27. Fulton, D., Ruan, L., Sood, S. G., Li, C, Zhang, Q., and Venema, R. C. (2008) Agonist-stimulated endothelial nitric oxide synthase activation and vascular relaxation. Role of eNOS phosphorylation at Tyr83. Circ. Res. 102, 497-504
28. Michell, B. J., Harris, M. B., Chen, Z. P., Ju, H., Venema, V. J., Blackstone, M. A., Huang, W., Venema, R. C, and Kemp, B. E. (2002) Identification of regulatory sites of phosphorylation of the bovine endothelial nitric-oxide synthase at serine 617 and serine 635. Biol. Chem. 277, 42344-42351
29. 2+ release modulates endothelial nitric-oxide synthase via extracellular signal-regulated kinase (ERK) 1/2-mediated serine 635 phosphorylation. Biol. Chem. 286, 20100-20108
30. Casanello, P., Krause, B., Torres, E., Gallardo, V., Gonzalez, M., Prieto, C., Escudero, C., Farias, M., and Sobrevia, L. (2009) Reduced L-arginine transport and nitric oxide synthesis in human umbilical vein endothelial cells from intrauterine growth restriction pregnancies is not further altered by hypoxia. Placenta 30, 625-633
31. Ussar, S., and Voss, T. (2004) MEKl andMEK2, different regulators of the Gj/S transition. Biol. Chem. 279, 43861-43869
32. 2-terminal kinases suppresses the growth of experimental head and neck squamous cell carcinoma. Clin. Cancer Res. 13, 5910-5917
33. Brovkovych, V., Stolarczyk, E., Oman, J., Tomboulian, P., and Malinski, T. (1999) Direct electrochemical measurement of nitric oxide in vascular endothelium. J. Pharm. Biomed. Anal. 19, 135-143
34. Liesmaa, I., Leskinen, H. K., Kokkonen, J. O., Ruskoaho, H, Kovanen, P. T., and Lindstedt, K. A. (2009) Hypoxia-induced expression of bradykinin type-2 receptors in endothelial cells triggers NO production, cell migration, and angiogenesis. Cell. Physiol. 221, 359-366
35. Liang, C. C., Park, A. Y., and Guan, J. L. (2007) In vitro scratch assay. A convenient and inexpensive method for analysis of cell migration in vitro. Nat. Protoc. 2, 329-333
36. 9]bradykinin, a B2 receptor selective agonist which is not broken down by either kininase I or kininase II. Eur. J. Pharmacol. 155, 193-195
37. Griffiths, C., and Garthwaite, J. (2001) The shaping of nitric oxide signals by a cellular sink. Physiol. 536, 855-862
38. Thomas, D. D., Ridnour, L. A., Isenberg, J. S., Flores-Santana, W., Switzer, C. H., Donzelli, S., Hussain, P., Vecoli, C., Paolocci, N, Ambs, S., Colton, C. A., Harris, C. C., Roberts, D. D., and Wink, D. A. (2008) The chemical biology of nitric oxide. Implications in cellular signaling. Free Radie. Biol. Med. 45, 18-31
39. Webb, A.J., Milsom, A. B., Rathod, K. S., Chu, W. L., Qureshi, S., Lovell, M. J., Lecomte, F. M., Perrett, D., Raimondo, C, Khoshbin, E., Ahmed, Z., Uppal, R., Benjamin, N, Hobbs, A. J., and Ahluwalia, A. (2008) Mechanisms underlying erythrocyte and endothelial nitrite reduction to nitric oxide in hypoxia. Role for xanthine oxidoreductase and endothelial nitric oxide synthase. Circ. Res. 103, 957-964
40. Closs, E. I. (2002) Expression, regulation, and function of carrier proteins for cationic amino acids. Curr. Opin. Nephrol. Hypertens. 11, 99-107
41. Liihrs, H, Papadopoulos, T., Schmidt, H. H., and Menzel, T. (2002) Type I nitric oxide synthase in the human lung is predominantly expressed in capillary endothelial cells. Respir. Physiol. 129, 367-374
42. Bachetti, T., Comini, L., Curello, S., Bastianon, D., Palmieri, M., Bresciani, G., Callea, F., and Ferrari, R. (2004) Co-expression and modulation of neuronal and endothelial nitric oxide synthase in human endothelial cells. Mol. Cell. Cardiol. 37, 939-945
43. Mantovani, A., Bussolino, F., and Dejana, E. (1992) Cytokine regulation of endothelial cell function. FASEB J. 6, 2591-2599
44. Ignjatovic, T., Stanisavljevic, S., Brovkovych, V., Skidgel, R. A., and Erdos, E. G. (2204) Kinin Bl receptors stimulate nitric oxide production in endothelial cells. Signaling pathways activated by angiotensin I-converting enzyme inhibitors and peptide ligands. Mol. Pharmacol. 66, 1310-1316
45. Zimmerman, B., Simaan, M., Akoume, M. Y., Houri, N, Chevallier, S., Séguéla, P., and Laporte, S. A. (2011) Role of β arrestins in bradykinin B2 receptor-mediated signaling. Cell. Signal. 23, 648-659
46. Closs, E. L, Scheld, J. S., Sharafi, M., and Förstermann, U. (2000) Substrate supply for nitric-oxide synthase in macrophages and endothelial cells. Role of cationic amino acid transporters. Mol. Pharmacol. 57, 68-74
47. Zhang, Y., Adner, M., and Cardell, L. O. (2007) IL-l/3-induced transcriptional up-regulation of bradykinin Bl and B2 receptors in murine airways. Am. J. Respir. Cell Mol. Biol. 36, 697-705
48. L signals. Mol. Cell. Biol. 20, 6837-6848
49. Adler, V., Qu, Y., Smith, S. J., Izotova, L., Pestka, S., Kung, H. F., Lin, M., Friedman, F. IC, Chie, L., Chung, D., Boutjdir, M., and Pincus, M. R. (2005) Functional interactions of Raf and MEK with Jun-N-terminal kinase (JNK) result in a positive feedback loop on the oncogenic Ras signaling pathway. Biochemistry 44, 10784-10795
50. 2 receptor-mediated mitogen-activated protein kinase activation in COS-7 cells requires dual signaling via both protein kinase C pathway and epidermal growth factor receptor transac-tivation. Mol. Cell. Biol. 19, 5289-5297
51. Ruan, L., Torres, C.M., Qian, J., Chen, F., Mintz, J.D., Stepp, D. W., Fulton, D., and Venema, R. C. (2011) Pinl prolyl isomerase regulates endothelial nitric oxide synthase. Arterioscler. Thromb. Vase. Biol. 31, 392-398
52. Park, J. H., Park, M., Byun, C. J., and Jo, I. (2012) c-Jun N-terminal kinase 2 phosphorylates endothelial nitric oxide synthase at serine 116 and regulates nitric oxide production. Biochem. Biophys. Res. Commun. 417, 340-345
53. Lamalice, L., Le Boeuf, F., and Huot, J. (2007) Endothelial cell migration during angiogenesis. Circ. Res. 100, 782-794
54. Soneja, A., Drews, M., and Malinski, T. (2005) Role of nitric oxide, nitroxi-dative, and oxidative stress in wound healing. Pharmacol. Rep. 57, 108-119
55. Lee, P. C, Salyapongse, A. N, Bragdon, G. A., Shears, L. L., 2nd, Watkins, S. C, Edington, H. D., and Billiar, T. R. (1999) Impaired wound healing and angiogenesis in eNOS-deficient mice. Am. J. Physiol. 277, H1600-H1608
56. Papapetropoulos, A., Rudic, R. D., and Sessa, W. C. (1999) Molecular control of nitric oxide synthases in the cardiovascular system. Cardiovasc. Res. 43, 509-520
57. MacMicking, J., Xie, Q.-W., and Nathan, C (1997) Nitric oxide and macrophage function. Annu. Rev. Immunol. 15, 323-350
58. Chan, G. C, Fish, J. E., Mawji, I. A., Leung, D. D., Rachlis, A. C, and Marsden, P. A. (2005) Epigenetic basis for the transcriptional hyporespon-siveness of the human inducible nitric oxide synthase gene in vascular endothelial cells. Immunol. 175, 3846-3861
59. Lancaster, J. R., Jr. (2006) Nitroxidative, nitrosative, and nitrative stress. Kinetic predictions of reactive nitrogen species chemistry under biological conditions. Chem. Res. Toxicol. 19, 1160-1174
60. Pacher, P., Beekman, J. S., and Liaudet, L. (2007) Nitric oxide and per-oxynitrite in health and disease. Physiol. Rev. 87, 315-424
61. Bellamy, T. C, Griffiths, C, and Garthwaite, J. (2002) Differential sensitivity of guanylyl cyclase and mitochondrial respiration to nitric oxide measured using clamped concentrations. Biol. Chem. 277, 31801-31807
62. Cho, H. J., Xie, Q. W., Calaycay, J., Mumford, R. A., Swiderek, IC M., Lee, T. D., and Nathan, C. (1992) Calmodulin is a subunit of nitric oxide synthase from macrophages. Exp. Med. 176, 599-604
63. Nishida, C. R., and Ortiz de Montellano, P. R. (1999) Autoinhibition of endothelial nitric-oxide synthase. Identification of an electron transfer control element. Biol. Chem. 274, 14692-14698
64. Salerno, J. C, Harris, D. E., Irizarry, IC, Patel, B., Morales, A. J., Smith, S. M., Martasek, P., Roman, L. J., Masters, B. S., Jones, C. L., Weissman, B. A., Lane, P., Liu, Q., and Gross, S. S. (1997) An autoinhibitory control element defines calcium-regulated isoforms of nitric oxide synthase. Biol. Chem. 272, 29769-29777
65. Chen, P. F., and Wu, K. K. (2003) Structural elements contribute to the calcium/calmodulin dependence on enzyme activation in human endothelial nitric-oxide synthase. Biol. Chem. 278, 52392-52400
66. Knudsen, G. M., Nishida, C. R., Mooney, S. D., and Ortiz de Montellano, P. R. (2003) Nitric-oxide synthase (NOS) reductase domain models suggest a new control element in endothelial NOS that attenuates calmodu-lin-dependent activity. Biol. Chem. 278, 31814-31824
67. Ramadoss, J., Liao, W. X., Morschauser, T. J., Lopez, G. E., Patankar, M. S., Chen, D. B., and Magness, R. R. (2012) Endothelial caveolar hub regulation of adenosine triphosphate-induced endothelial nitric oxide synthase subcellular partitioning and domain-specific phosphorylation. Hypertension 59, 1052-1059
68. Haeusgen, W., Herdegen, T., and Waetzig, V. (2011) The bottleneck of INK signaling. Molecular and functional characteristics of MKK4 and MKK7. Eur. J. Cell Biol. 90, 536-544
69. Goldsmith, Z. G., and Dhanasekaran, D. N. (2007) G protein regulation of MAPK networks. Oncogene 26, 3122-3142
70. r dependent activation of c-Jun N-terminal kinase in human embryonal kidney 293 cells. Biol. Chem. 275, 7633-7640
71. Coso, O. A., Teramoto, H., Simonds, W. F., and Gutkind, J. S. (1996) Signaling from G protein-coupled receptors to c-Jun kinase involves 187 subunits of heterotrimeric G proteins acting on a Ras and Racl-dependent pathway. Biol. Chem. 271, 3963-3966
72. Bogoyevitch, M. A., and Kobe, B. (2006) Uses for JNK. The many and varied substrates of the c-Jun N-terminal kinases. Microbiol. Mol. Biol. Rev. 70, 1061-1095
73. Engström, W., Ward, A., and Moorwood, K. (2010) The role of scaffold proteins in JNK signalling. Cell Prolif. 43, 56-66
74. Skidgel, R. A. (2002) Proliferation of regulatory mechanisms for eNOS. An emerging role for the cytoskeleton. Ara. Physiol. Lung Cell Mol. Physiol. 282, L1179-L1182
75. s target lipid rafts by default. Mol. Biol. Cell 12, 685-698
76. Solomonson, L. P., Flam, B. R., Pendleton, L. C, Goodwin, B. L., and Eichler, D. C. (2003) The caveolar nitric oxide synthase/arginine regeneration system for NO production in endothelial cells. Exp. Biol. 206, 2083-2087
77. Fessier, M. B., and Parks, J. S. (2011) Intracellular lipid flux and membrane microdomains as organizing principles in inflammatory cell signaling. Immunol. 187, 1529-1535
78. Morais, C, Ebrahem, Q., Anand-Apte, B., and Parat, M. O. (2012) Altered angiogenesis in caveolin-1 gene-deficient mice is restored by ablation of endothelial nitric oxide synthase. Am. Pathol. 180, 1702-1714
79. Koika, V., Zhou, Z., Vasileiadis, I., Roussos, C, Finetti, F., Monti, M., Mor-bidelli, L., and Papapetropoulos, A. (2010) PKG-I inhibition attenuates vascular endothelial growth factor-stimulated angiogenesis. Vascul. Pharmacol. 53, 215-222
80. Mehta, D., and Malik, A. B. (2006) Signaling mechanisms regulating endothelial permeability. Physiol. Rev. 86, 279-367
81. Kubes, P. (1995) Nitric oxide affects microvascular permeability in the intact and inflamed vasculature. Microcirculation 2, 235-244
82. Schubert, W., Frank, P. G., Woodman, S. E., Hyogo, H., Cohen, D. E., Chow, C. W., and Lisanti, M. P. (2002) Microvascular hyperpermeability in caveolin-l(-/-) knock-out mice. Treatment with a specific nitric-oxide synthase inhibitor, L-NAME, restores normal microvascular permeability in Cav-1 null mice. Biol. Chem. 277, 40091-40098
83. Miyawaki-Shimizu, IC, Predescu, D., Shimizu, J., Broman, M., Predescu, S., and Malik, A. B. (2006) siRNA-induced caveolin-1 knockdown in mice increases lung vascular permeability via the junctional pathway. Am. J. Physiol. Lung Cell Mol. Physiol. 290, L405-L413
84. Predescu, D., Predescu, S., Shimizu, J., Miyawaki-Shimizu, IC, and Malik, A. B. (2005) Constitutive eNOS-derived nitric oxide is a determinant of endothelial junctional integrity. Am. J. Physiol. Lung Cell Mol. Physiol. 289, L371-L381
85. Yuan, S. Y. (2000) Signal transduction pathways in enhanced microvascular permeability. Microcirculation 7, 395-403
86. Thibeault, S., Rautureau, Y., Oubaha, M., Faubert, D., Wilkes, B. C, Del-isle, C, and Gratton, J. P. (2010) S-Nitrosylation of β-catenin by eNOS-derived NO promotes VEGF-induced endothelial cell permeability. Mol. Cell 39, 468-476
87. Gavard, J., and Gutkind, J. S. (2006) VEGF controls endothelial-cell permeability by promoting the β-arrestin-dependent endocytosis of VE-cad-herin. Nat Cell Biol. 8, 1223-1234
88. Ozawa, IC, Whalen, E. J., Nelson, C. D., Mu, Y., Hess, D. T., Lefkowitz, R. J., and Stamler, J. S. (2008) S-Nitrosylation of β-arrestin regulates β-adrener-gic receptor trafficking. Mol. CellSl, 395-405
89. Wu, F., and Wilson, J. X. (2009) Peroxynitrite-dependent activation of protein phosphatase type 2A mediates microvascular endothelial barrier dysfunction. Cardiovasc. Res. 81, 38-45
90. Neumann, P., Gertzberg, N., Vaughan, E., Weisbrot, J., Woodbum, R., Lambert, W., and Johnson, A. (2006) Peroxynitrite mediates TNF-a-in-duced endothelial barrier dysfunction and nitration of actin. Am. J. Physiol. Lung Cell Mol. Physiol. 290, L674-L684
91. Siddiqui, M. R., Komarova, Y. A., Vogel, S. M., Gao, X., Bonini, M. G., Rajasingh, J., Zhao, Y. Y., Brovkovych, V., and Malik, A. B. (2011) Caveolin-1-eNOS signaling promotes pl90RhoGAP-A nitration and endothelial permeability. Cell Biol. 193, 841-850